Brief: Glenmark Pharmaceuticals Inc., USA Launches Vancomycin Hydrochloride For Injection USP, 750 Mg/Vial, 1.25 G/Vial And 1.5 G/Vial (Single-Dose Vial)
01/04/2025 12:04
April 1 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS: GLENMARK PHARMACEUTICALS INC., USA LAUNCHES VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP, 750 MG/VIAL, 1.25 G/VIAL AND 1.5 G/VIAL (SINGLE-DOSE VIAL) Source text: ID:nPn4wYPFna Further company coverage: GLEN.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Unit Launches Ryaltris Nasal Spray In Brazil For Allergic Rhinitis
Brief: Glenmark Pharma US Unit Launches Calcium Gluconate Injection USP In Multiple Vial Sizes
India's Glenmark Pharma gains most in three weeks on US approval for Flonase nasal spray
Brief: Glenmark Pharma Gets U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg/Spray
India's Glenmark Pharmaceuticals falls as brokerage flags softer-than-expected quarter